Queen's University at Kingston
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1841-10-16
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.queensu.ca
The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 93
- Registration Number
- NCT02394600
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
Clinical Validation of Birch Pollen in the EEU
- Conditions
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 59
- Registration Number
- NCT02351830
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD
- Conditions
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 22
- Registration Number
- NCT02346604
- Locations
- 🇨🇦
Respiratory Investigation Unit at Kingston General Hospital, Kingston, Ontario, Canada
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
- Conditions
- Interventions
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 7
- Registration Number
- NCT02343718
- Locations
- 🇨🇦
Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
🇨🇦CHU Sainte-Justine, Montreal, Quebec, Canada
🇨🇦Hospital for Sick Children, Toronto, Ontario, Canada
Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness
- Conditions
- Interventions
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 116
- Registration Number
- NCT02344043
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia
- First Posted Date
- 2015-01-19
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 14
- Registration Number
- NCT02340780
- Locations
- 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦University Health Network, Toronto, Ontario, Canada
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
- Conditions
- Interventions
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 62
- Registration Number
- NCT02337530
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
🇨🇦CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
MindLight: A Video Game Intervention to Reduce Children's Anxiety
- First Posted Date
- 2014-12-29
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 200
- Registration Number
- NCT02326545
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis
- Conditions
- Interventions
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 50
- Registration Number
- NCT02320500
- Locations
- 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada
MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
- Conditions
- Interventions
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 56
- Registration Number
- NCT02285816
- Locations
- 🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦Ottawa Hospital Research Institute, Ottawa, Ontario, Canada